Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Collegium Pharmaceutical
Collegium Pharmaceutical
(COLL)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Nucynta
Tapentadol
2008-11-20
2024-2028
Pain
Xtampza
Oxycodone
2016-04-26
2024-2036
Pain
,
Fever
,
Postoperative pain
,
Alcoholism
,
Opioid-related disorders
,
Drug overdose
,
Juvenile arthritis
,
Menorrhagia
,
Ankylosing spondylitis
,
Rheumatoid arthritis
,
Inflammation
,
Osteoarthritis
,
Bursitis
,
Dysmenorrhea
,
Gout
,
Premenstrual syndrome
,
Rheumatic fever
,
Septic shock
,
Respiration disorders
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Oxycodone
healthy volunteers/patients
Aspartame
healthy volunteers/patients
,
alzheimer disease
,
female genital neoplasms
,
melanoma
,
chronic hepatitis b
,
depression
,
major depressive disorder
,
depressive disorder
,
triple negative breast neoplasms
,
pancreatic neoplasms
,
coronary disease
,
coronary artery disease
,
myocardial ischemia
,
heart diseases
,
lung neoplasms
,
sickle cell anemia
,
sarcoma
,
glioma
,
neuroblastoma
,
precursor cell lymphoblastic leukemia-lymphoma
,
parkinson disease
,
autistic disorder
,
autism spectrum disorder
,
pervasive child development disorders
,
chronic hepatitis
,
rectal neoplasms
,
covid-19
,
pneumonia
,
leukemia
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
,
exanthema
,
nasopharyngeal carcinoma
,
nasopharyngeal neoplasms
,
stomach neoplasms
,
esophageal neoplasms
,
adenocarcinoma
,
neoplasm metastasis
,
antiphospholipid syndrome
,
respiratory insufficiency
,
neoplasms
,
colorectal neoplasms
,
non-small-cell lung carcinoma
,
lupus nephritis
,
human influenza
,
breast neoplasms
,
anemia
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
,
non-hodgkin lymphoma
,
myeloid leukemia acute
,
multiple sclerosis
,
nephritis
,
hepatocellular carcinoma
,
colonic neoplasms
,
thrombocytopenic purpura idiopathic
,
liver cirrhosis
,
neuromyelitis optica
,
membranous glomerulonephritis
,
chronic progressive multiple sclerosis
,
relapsing-remitting multiple sclerosis
,
nephrotic syndrome
,
ovarian neoplasms
,
ovarian epithelial carcinoma
,
hemolysis
,
hemolytic anemia autoimmune
,
hepatitis c
,
chronic hepatitis c
,
hepatitis
,
hepatitis a
,
rheumatoid arthritis
,
lymphoma
,
arthritis
,
juvenile arthritis
,
hiv infections
,
follicular lymphoma
,
asthma
,
heart failure
,
myelodysplastic syndromes
,
preleukemia
,
syndrome
,
acquired immunodeficiency syndrome
,
kidney transplantation
,
drug-related side effects and adverse reactions
,
heart disease risk factors
,
cognitive dysfunction
Phenylacetic acid
breast neoplasms
,
congenital abnormalities
,
postoperative pain
,
toothache
,
wounds and injuries
,
contusions
,
soft tissue injuries
,
sprains and strains
,
sunburn
,
attention deficit disorder with hyperactivity
,
hyperkinesis
,
ankle injuries
,
respiratory tract infections
,
infections
,
pain
,
myalgia
,
arthralgia
,
communicable diseases
,
fever
,
substance-related disorders
Hld200
attention deficit disorder with hyperactivity
,
hyperkinesis
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use